Cervical cancer
Conditions
Interventions
Case series:CalliSpheres loaded drug embolic microspheres loaded with irinotecan with DEB-TACE
Sponsors
Department of gynaecology in the west coast of Affiliated Hospital of Qingdao University Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) understanding and signing informed consent; 2) Aged 18-75 years; 3) cervical cancer is diagnosed by histopathology or clinical diagnosis (refer to the 2016 edition of NCCN clinical practice guideline cervical cancer); 4) patients with stage B1, stage I, B2, II A and stage II B cervical cancer; 5) a recurrent tumor that can not be completely removed by a variety of factors; patients with intermediate and late tumor, who are unexcised or unwilling to be excised, have a preoperatively descending patient; 6) hemorrhage of tumor and metastasis; 7) the expected survival time is more than 3 months; 8) the physical capacity of ECOG is less than 2.
Exclusion criteria
Exclusion criteria: 1) patients with or without other malignancies (except cured basal or squamous cell carcinoma or cervical carcinoma in situ); 2) a history of major diseases involving heart, kidney, bone marrow or lung and central nervous system; 3) recent infection needs antibiotics; 4) there are four clinical trials involving other experimental drugs or devices within four weeks; 5) can cause the subjects to fail to follow the research plan or even endanger the patient's safety complications or social environment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS; | — |
Secondary
| Measure | Time frame |
|---|---|
| ????;ORR;DCR; | — |
Countries
China
Contacts
Public ContactYao Qin
West Coast Hospital area, Affiliated Hospital of Qingdao University Medical College, Huangdao District, Qingdao, Shandong, China
Outcome results
None listed